CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Ethereum was built with Turing-complete smart contracts, unlike Bitcoin. This explanation covers the architectural reasons and practical impact.
28,562 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
A Delaware bankruptcy judge cleared Terraform’s Plan Administrator to use Jump Trading documents in a roughly $4 bill...
Oracle confronts a heavy debt burden and sweeping layoffs as it presses ahead with a three-step transformation, raisi...
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
This average social security is a key piece of retirement planning. In 2026, the typical 67-year-old can expect to re...
Banking, housing finance groups urge federal regulators to tailor Basel III capital rules, arguing that overlap and h...
As Netflix faces slowing growth, the question on investors' minds is simple: could the streamer be about to buy somet...
A high-profile trust dispute offers real-world lessons on how to protect your assets and family. Learn practical step...
A beginner-friendly look at how big investment moves in real estate investment trusts signal risk and income opportun...
Beijing’s June trade data show a hefty export push that masks weak domestic demand, creating a controversial escape v...
A confidential settlement in Maryland ends a high-profile dispute over HeLa cell patents and profits, signaling a new...
As families navigate aging-parent care, adding names to bank accounts can backfire, exposing both sides to liabilitie...